{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:34:45Z","timestamp":1783524885004,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Group B Streptococcus (GBS) is generally an asymptomatic colonizer of human mucosa but it occasionally infects pregnant women and neonates through vertical transmission, causing disease during the first weeks of life with frequent and severe complications. Preclinical studies have shown that maternal vaccination with polysaccharide-based vaccines protects mothers and offspring from GBS mucosal colonization and consecutive infection. In these models, bacteria were inoculated in mouse either intravaginally in the last trimester of pregnancy or systemically in pups. Here, we investigated whether maternal vaccination with glycoconjugate vaccines may also prevent GBS-mediated colonization and disease in neonates using an infection route that more closely mimics inhalation or ingestion of bacteria during human delivery. To address this point, mice aged less than two days were intranasally challenged with epidemiologically relevant GBS strains. Bacteria were found to colonize nose and intestine, reaching in some cases lungs and blood during the first days of life. Bacteria were also found in vagina of a fraction of colonized female mice within the first month of life. GBS-specific IgG induced by maternal vaccination with a glycoconjugate vaccine formulation were found in blood and mucosal tissues of newborns. Finally, when intranasally challenged with GBS serotype III strains, pups delivered by vaccinated mothers were partially protected against mucosal colonization and deeper infection.<\/jats:p>","DOI":"10.1038\/s41598-021-00941-z","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T11:04:13Z","timestamp":1635764653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection"],"prefix":"10.1038","volume":"11","author":[{"given":"Emiliano","family":"Chiarot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Naimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada Margarit Y.","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Bensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"941_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/jcp.2005.029058","volume":"59","author":"N Jones","year":"2006","unstructured":"Jones, N., Oliver, K., Jones, Y., Haines, A. & Crook, D. Carriage of group B streptococcus in pregnant women from Oxford, UK. J. Clin. Pathol. 59, 363\u2013366. https:\/\/doi.org\/10.1136\/jcp.2005.029058 (2006).","journal-title":"J. Clin. Pathol."},{"key":"941_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bpobgyn.2007.01.003","volume":"21","author":"PT Heath","year":"2007","unstructured":"Heath, P. T. & Schuchat, A. Perinatal group B streptococcal disease. Best Pract. Res. Clin. Obstet. Gynaecol. 21, 411\u2013424. https:\/\/doi.org\/10.1016\/j.bpobgyn.2007.01.003 (2007).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"941_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1128\/jcm.42.1.83-89.2004","volume":"42","author":"SM Hansen","year":"2004","unstructured":"Hansen, S. M., Uldbjerg, N., Kilian, M. & S\u00f8rensen, U. B. S. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J. Clin. Microbiol. 42, 83\u201389. https:\/\/doi.org\/10.1128\/jcm.42.1.83-89.2004 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"941_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/cmr.00031-13","volume":"27","author":"KA Simonsen","year":"2014","unstructured":"Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F. & Davies, H. D. Early-onset neonatal sepsis. Clin. Microbiol. Rev. 27, 21\u201347. https:\/\/doi.org\/10.1128\/cmr.00031-13 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"941_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.05.013","author":"J Vornhagen","year":"2017","unstructured":"Vornhagen, J., Adams Waldorf, K. M. & Rajagopal, L. Perinatal group B streptococcal infections: Virulence factors, immunity, and prevention strategies. Trends Microbiol. https:\/\/doi.org\/10.1016\/j.tim.2017.05.013 (2017).","journal-title":"Trends Microbiol."},{"key":"941_CR6","doi-asserted-by":"publisher","first-page":"D7","DOI":"10.1016\/j.vaccine.2013.01.009","volume":"31","author":"K Le Doare","year":"2013","unstructured":"Le Doare, K. & Heath, P. T. An overview of global GBS epidemiology. Vaccine 31, D7\u2013D12. https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.009 (2013).","journal-title":"Vaccine"},{"key":"941_CR7","doi-asserted-by":"publisher","unstructured":"Stoll, B. J. Early-onset neonatal sepsis: A continuing problem in need of novel prevention strategies. Pediatrics 138. https:\/\/doi.org\/10.1542\/peds.2016-3038 (2016).","DOI":"10.1542\/peds.2016-3038"},{"key":"941_CR8","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0163-4453(17)30189-5","volume":"74","author":"P Zimmermann","year":"2017","unstructured":"Zimmermann, P., Gwee, A. & Curtis, N. The controversial role of breast milk in GBS late-onset disease. J. Infect. 74, S34\u2013S40. https:\/\/doi.org\/10.1016\/S0163-4453(17)30189-5 (2017).","journal-title":"J. Infect."},{"key":"941_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-3476(87)80283-4","volume":"110","author":"HC Dillon Jr","year":"1987","unstructured":"Dillon, H. C. Jr., Khare, S. & Gray, B. M. Group B streptococcal carriage and disease: A 6-year prospective study. J. Pediatr. 110, 31\u201336. https:\/\/doi.org\/10.1016\/S0022-3476(87)80283-4 (1987).","journal-title":"J. Pediatr."},{"key":"941_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1586\/14787210.2015.1079126","volume":"13","author":"A Berardi","year":"2015","unstructured":"Berardi, A. et al. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination. Expert Rev. Anti Infect. Ther. 13, 1387\u20131399. https:\/\/doi.org\/10.1586\/14787210.2015.1079126 (2015).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"941_CR11","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/cid\/ciz033","volume":"69","author":"A Tazi","year":"2019","unstructured":"Tazi, A. et al. Risk factors for infant colonization by hypervirulent CC17 Group B Streptococcus: Toward the understanding of late-onset disease. Clin. Infect. Dis. 69, 1740\u20131748. https:\/\/doi.org\/10.1093\/cid\/ciz033 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"941_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/s1473-3099(14)70919-3","volume":"14","author":"V Bekker","year":"2014","unstructured":"Bekker, V., Bijlsma, M. W., van de Beek, D., Kuijpers, T. W. & van der Ende, A. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: A nationwide surveillance study. Lancet. Infect. Dis 14, 1083\u20131089. https:\/\/doi.org\/10.1016\/s1473-3099(14)70919-3 (2014).","journal-title":"Lancet. Infect. Dis"},{"key":"941_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826%JJAMAPediatrics","volume":"173","author":"SA Nanduri","year":"2019","unstructured":"Nanduri, S. A. et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: Multistate laboratory and population-based surveillance. JAMA Pediatr. 173, 224\u2013233. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.4826%JJAMAPediatrics (2019).","journal-title":"JAMA Pediatr."},{"key":"941_CR14","doi-asserted-by":"publisher","unstructured":"Phares, C. R., Lynfield, R., Farley, M. M. et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005. JAMA 299, 2056\u20132065. https:\/\/doi.org\/10.1001\/jama.299.17.2056 (2008).","DOI":"10.1001\/jama.299.17.2056"},{"key":"941_CR15","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3201\/eid2611.201669","volume":"26","author":"C Plainvert","year":"2020","unstructured":"Plainvert, C. et al. Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007\u20132019. Emerg. Infect. Dis. 26, 2721\u20132724. https:\/\/doi.org\/10.3201\/eid2611.201669 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"941_CR16","doi-asserted-by":"publisher","unstructured":"Cho, C.-Y. et al. Group B streptococcal infection in neonates and colonization in pregnant women: an epidemiological retrospective analysis. J. Microbiol. Immunol. Infect. https:\/\/doi.org\/10.1016\/j.jmii.2017.08.004 (2017).","DOI":"10.1016\/j.jmii.2017.08.004"},{"key":"941_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2008\/727505","volume":"2008","author":"ML Castor","year":"2008","unstructured":"Castor, M. L. et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect. Dis. Obstet. Gynecol. 2008, 5. https:\/\/doi.org\/10.1155\/2008\/727505 (2008).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"941_CR18","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/aac.00185-08","volume":"52","author":"K Kimura","year":"2008","unstructured":"Kimura, K. et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52, 2890\u20132897. https:\/\/doi.org\/10.1128\/aac.00185-08 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"941_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/2051013615579869","volume":"3","author":"A Nuccitelli","year":"2015","unstructured":"Nuccitelli, A., Rinaudo, C. D. & Maione, D. Group B streptococcus vaccine: State of the art. Ther. Adv. Vaccines 3, 76\u201390. https:\/\/doi.org\/10.1177\/2051013615579869 (2015).","journal-title":"Ther. Adv. Vaccines"},{"key":"941_CR20","doi-asserted-by":"publisher","unstructured":"Bokulich, N. A. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med. 8, 343ra382\u2013343ra382. https:\/\/doi.org\/10.1126\/scitranslmed.aad7121 (2016).","DOI":"10.1126\/scitranslmed.aad7121"},{"key":"941_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","volume":"379","author":"KM Edmond","year":"2012","unstructured":"Edmond, K. M. et al. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet 379, 547\u2013556. https:\/\/doi.org\/10.1016\/S0140-6736(11)61651-6 (2012).","journal-title":"Lancet"},{"key":"941_CR22","doi-asserted-by":"publisher","unstructured":"Kobayashi, M. et al. Group B Streptococcus vaccine development: Present status and future considerations, with emphasis on perspectives for low and middle income countries [version 1; peer review: 2 approved]. 5. https:\/\/doi.org\/10.12688\/f1000research.9363.1 (2016).","DOI":"10.12688\/f1000research.9363.1"},{"key":"941_CR23","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/s41598-018-20609-5","volume":"8","author":"E Chiarot","year":"2018","unstructured":"Chiarot, E. et al. Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models. Sci. Rep. 8, 2593. https:\/\/doi.org\/10.1038\/s41598-018-20609-5 (2018).","journal-title":"Sci. Rep."},{"issue":"114","key":"941_CR24","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.ajog.2007.06.003","volume":"198","author":"DA Santillan","year":"2008","unstructured":"Santillan, D. A., Andracki, M. E. & Hunter, S. K. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase. Am. J. Obstet. Gynecol. 198(114), e111-114.e116. https:\/\/doi.org\/10.1016\/j.ajog.2007.06.003 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"941_CR25","unstructured":"Verani, J. R., McGee, L. & Schrag, S. J. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC, 2010. in Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). MMWR Recommendations Reports 2010 Nov 19; 59(RR-10):1\u201336. (2010)."},{"key":"941_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/bdrb.20201","volume":"86","author":"N Pent\u0161uk","year":"2009","unstructured":"Pent\u0161uk, N. & van der Laan, J. W. An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res. B 86, 328\u2013344. https:\/\/doi.org\/10.1002\/bdrb.20201 (2009).","journal-title":"Birth Defects Res. B"},{"issue":"76","key":"941_CR27","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.ajog.2009.02.011","volume":"201","author":"LA Meyn","year":"2009","unstructured":"Meyn, L. A., Krohn, M. A. & Hillier, S. L. Rectal colonization by Group B Streptococcus as a predictor of vaginal colonization. Am. J. Obstet. Gynecol. 201(76), e71-76.e77. https:\/\/doi.org\/10.1016\/j.ajog.2009.02.011 (2009).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"941_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fmicb.2018.00437","volume":"9","author":"S Shabayek","year":"2018","unstructured":"Shabayek, S. & Spellerberg, B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front. Microbiol. 9, 437. https:\/\/doi.org\/10.3389\/fmicb.2018.00437 (2018).","journal-title":"Front. Microbiol."},{"key":"941_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/infdis\/135.2.308","volume":"135","author":"MS Badri","year":"1977","unstructured":"Badri, M. S. et al. Rectal colonization with Group B Streptococcus: Relation to vaginal colonization of pregnant women. J. Infect. Dis. 135, 308\u2013312. https:\/\/doi.org\/10.1093\/infdis\/135.2.308 (1977).","journal-title":"J. Infect. Dis."},{"key":"941_CR30","doi-asserted-by":"publisher","unstructured":"Chan G.J. et al. Early\u2010onset neonatal sepsis in Dhaka, Bangladesh: Risk associated with maternal bacterial colonisation and chorioamnionitis. Trop. Med. Int. Health 18, 1057\u20131064. https:\/\/doi.org\/10.1111\/tmi.12150 (2013).","DOI":"10.1111\/tmi.12150"},{"key":"941_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clp.2007.03.012","volume":"34","author":"HN Winn","year":"2007","unstructured":"Winn, H. N. Group B Streptococcus infection in pregnancy. Clin. Perinatol. 34, 387\u2013392. https:\/\/doi.org\/10.1016\/j.clp.2007.03.012 (2007).","journal-title":"Clin. Perinatol."},{"key":"941_CR32","doi-asserted-by":"publisher","unstructured":"Vornhagen, J., Adams Waldorf, K. M. & Rajagopal, L. Perinatal Group B Streptococcal infections: Virulence factors, immunity, and prevention strategies. Trends Microbiol. 25, 919\u2013931. https:\/\/doi.org\/10.1016\/j.tim.2017.05.013 (2017).","DOI":"10.1016\/j.tim.2017.05.013"},{"key":"941_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/17460913.4.2.201","volume":"4","author":"L Rajagopal","year":"2009","unstructured":"Rajagopal, L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol. 4, 201\u2013221. https:\/\/doi.org\/10.2217\/17460913.4.2.201 (2009).","journal-title":"Future Microbiol."},{"key":"941_CR34","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1017\/S1462399408000811","volume":"10","author":"HC Maisey","year":"2008","unstructured":"Maisey, H. C., Doran, K. S. & Nizet, V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev. Mol. Med. 10, e27\u2013e27. https:\/\/doi.org\/10.1017\/S1462399408000811 (2008).","journal-title":"Expert Rev. Mol. Med."},{"key":"941_CR35","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","volume":"31","author":"SJ Schrag","year":"2013","unstructured":"Schrag, S. J. & Verani, J. R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 31, D20\u2013D26. https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.056 (2013).","journal-title":"Vaccine"},{"key":"941_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/cid\/ciw377","volume":"63","author":"M Fabbrini","year":"2016","unstructured":"Fabbrini, M. et al. The protective value of maternal group B streptococcus antibodies: Quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera. Clin. Infect. Dis. 63, 746\u2013753. https:\/\/doi.org\/10.1093\/cid\/ciw377 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"941_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/adc.88.5.375","volume":"88","author":"CJ Baker","year":"2003","unstructured":"Baker, C. J. & Edwards, M. S. Group B streptococcal conjugate vaccines. Arch. Dis. Child. 88, 375\u2013378. https:\/\/doi.org\/10.1136\/adc.88.5.375 (2003).","journal-title":"Arch. Dis. Child."},{"key":"941_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/infdis\/jit549","volume":"209","author":"CJ Baker","year":"2014","unstructured":"Baker, C. J. et al. Maternal antibody at delivery protects neonates from early onset Group B streptococcal disease. J. Infect. Dis. 209, 781\u2013788. https:\/\/doi.org\/10.1093\/infdis\/jit549 (2014).","journal-title":"J. Infect. Dis."},{"key":"941_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.vaccine.2006.07.018","volume":"25","author":"CJ Baker","year":"2007","unstructured":"Baker, C. J., Rench, M. A., Paoletti, L. C. & Edwards, M. S. Dose\u2013response to type V group B streptococcal polysaccharide\u2013tetanus toxoid conjugate vaccine in healthy adults. Vaccine 25, 55\u201363. https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.018 (2007).","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"941_CR40","doi-asserted-by":"publisher","first-page":"D13","DOI":"10.1016\/j.vaccine.2012.12.080","volume":"31","author":"VL Chen","year":"2013","unstructured":"Chen, V. L., Avci, F. Y. & Kasper, D. L. A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine 31(Suppl 4), D13\u2013D19. https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.080 (2013).","journal-title":"Vaccine"},{"key":"941_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017861","volume":"6","author":"M Madzivhandila","year":"2011","unstructured":"Madzivhandila, M. et al. Serotype distribution and invasive potential of Group B Streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS ONE 6, e17861. https:\/\/doi.org\/10.1371\/journal.pone.0017861 (2011).","journal-title":"PLoS ONE"},{"key":"941_CR42","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1086\/314955","volume":"180","author":"LC Paoletti","year":"1999","unstructured":"Paoletti, L. C. et al. Synthesis and preclinical evaluation of glycoconjugate vaccines against Group B Streptococcus types VI and VIII. J. Infect. Dis. 180, 892\u2013895. https:\/\/doi.org\/10.1086\/314955 (1999).","journal-title":"J. Infect. Dis."},{"key":"941_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1086\/314574","volume":"179","author":"CJ Baker","year":"1999","unstructured":"Baker, C. J. et al. Safety and immunogenicity of capsular polysaccharide\u2014Tetanus toxoid conjugate vaccines for Group B streptococcal types Ia and Ib. J. Infect. Dis. 179, 142\u2013150. https:\/\/doi.org\/10.1086\/314574 (1999).","journal-title":"J. Infect. Dis."},{"key":"941_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1159\/000355656","volume":"35","author":"JDL Bergeron","year":"2013","unstructured":"Bergeron, J. D. L. et al. White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation. Dev. Neurosci. 35, 504\u2013515 (2013).","journal-title":"Dev. Neurosci."},{"key":"941_CR45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41577-019-0261-1","volume":"20","author":"K Chen","year":"2020","unstructured":"Chen, K., Magri, G., Grasset, E. K. & Cerutti, A. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat. Rev. Immunol. 20, 427\u2013441. https:\/\/doi.org\/10.1038\/s41577-019-0261-1 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"941_CR46","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1016\/s0264-410x(03)00336-0","volume":"21","author":"P Van de Perre","year":"2003","unstructured":"Van de Perre, P. Transfer of antibody via mother\u2019s milk. Vaccine 21, 3374\u20133376. https:\/\/doi.org\/10.1016\/s0264-410x(03)00336-0 (2003).","journal-title":"Vaccine"},{"key":"941_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11095-008-9724-y","volume":"26","author":"B Heurtault","year":"2009","unstructured":"Heurtault, B. et al. Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity. Pharm. Res. 26, 276\u2013285. https:\/\/doi.org\/10.1007\/s11095-008-9724-y (2009).","journal-title":"Pharm. Res."},{"key":"941_CR48","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez, A., Rottenberg, M., Tj\u00e4rnlund, A. & Fern\u00e1ndez, C. Immunoglobulin A and CD8+ T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae. 63, 177\u2013183. https:\/\/doi.org\/10.1111\/j.1365-3083.2006.01725.x (2006).","DOI":"10.1111\/j.1365-3083.2006.01725.x"},{"key":"941_CR49","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","volume":"12","author":"F Su","year":"2016","unstructured":"Su, F., Patel, G. B., Hu, S. & Chen, W. Induction of mucosal immunity through systemic immunization: Phantom or reality?. Hum. Vaccine Immunother. 12, 1070\u20131079. https:\/\/doi.org\/10.1080\/21645515.2015.1114195 (2016).","journal-title":"Hum. Vaccine Immunother."},{"key":"941_CR50","doi-asserted-by":"publisher","unstructured":"Maione, D. et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science (New York, N.Y.) 309, 148\u2013150. https:\/\/doi.org\/10.1126\/science.1109869 (2005).","DOI":"10.1126\/science.1109869"},{"key":"941_CR51","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1073\/pnas.1701885114","volume":"114","author":"F Carboni","year":"2017","unstructured":"Carboni, F. et al. Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide. Proc. Natl. Acad. Sci. 114, 5017\u20135022. https:\/\/doi.org\/10.1073\/pnas.1701885114 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"941_CR52","doi-asserted-by":"publisher","unstructured":"Corrado, A. et al. Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination. Sci. Rep. 6, 38043. https:\/\/doi.org\/10.1038\/srep38043.https:\/\/www.nature.com\/articles\/srep38043#supplementary-information (2016).","DOI":"10.1038\/srep38043."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00941-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:53:19Z","timestamp":1670086399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00941-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00941-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was sponsored by Novartis Vaccines and Diagnostics Srl, currently owned by the GSK group of companies. All authors have declared the following interests: all authors were employees of Novartis Vaccines at the time of the study. Following the acquisition of Novartis Vaccines by the GSK group of companies in March 2015, all but EN, and AC are now employees of the GSK group of companies. IMR and GB report ownership of GSK shares and\/or restricted GSK shares.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21384"}}